Coming – February 28

A Phase 3-ready Solution For Emergency Treatment Of Acute Ischemic Stroke

Date and Time

February 28

12:00 PM ET 9:00 AM PT

Webinar Details provided upon RSVP Approval

About this Event

Every forty seconds, someone in the US experiences a stroke – a devastating medical emergency affecting one in four people in their lifetime. Despite stroke being the world’s #1 cause for disability and #2 cause for death, there has been no drug approved since 1995.

FreeOx Biotech has developed Ox-01, a Phase III-ready disruptive solution as an adjunct to Mechanical Thrombectomy in the emergency treatment of Acute Ischemic Stroke. In a 421-patient Phase IIb trial, Ox-01 demonstrated a remarkable improvement in patient outcomes when combined with the current standard of care.

Register now to join this webinar with:

Emmett-Phil Coriat: Chairman & CEO, FreeOx

They’ll discuss why the massive benefits of this Phase III-ready solution for the emergency treatment of acute Ischemic Stroke

Sign Up Today


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.